Therapeutic strategies for hepatic fibro
β
Mario Chojkier; David A. Brenner
π
Article
π
1988
π
John Wiley and Sons
π
English
β 911 KB
The mechanisms responsible for the increased hepatic connective tissue deposition in cirrhosis remain unknown; and there is no established therapy for hepatic fibrosis. In this issue of Hepatology, Ruwart et al. (1) report that 16,16-dimethyl prostaglandin E2 (DMPG) inhibits hepatic collagen deposit